Geode Capital Management LLC Acquires 64,542 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Geode Capital Management LLC boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,612,370 shares of the medical instruments supplier's stock after buying an additional 64,542 shares during the quarter. Geode Capital Management LLC owned about 1.82% of DENTSPLY SIRONA worth $68,584,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Riverview Trust Co acquired a new position in DENTSPLY SIRONA during the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares in the last quarter. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares during the period. Finally, Signaturefd LLC boosted its stake in DENTSPLY SIRONA by 513.3% during the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after buying an additional 3,706 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

Remove Ads

Insiders Place Their Bets

In other news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.52% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on XRAY shares. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research report on Tuesday. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Wells Fargo & Company dropped their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Finally, Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Thirteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Stock Down 4.1 %

Shares of DENTSPLY SIRONA stock traded down $0.53 during trading hours on Tuesday, reaching $12.55. 3,114,940 shares of the company's stock were exchanged, compared to its average volume of 2,949,863. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a 50 day moving average of $15.95 and a two-hundred day moving average of $18.96. The stock has a market cap of $2.50 billion, a P/E ratio of -6.06, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.13.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 5.10%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.